Unprecedented Meroterpenoids Exert Anti-inflammatory Activity by Targeting NF-κB and PI3K Signaling Pathways
Organic Letters · 2026
DOI: 10.1021/acs.orglett.5c04695 ↗Kurz gefasst
Fachartikel in der Zeitschrift Organic Letters, 2026. Verfasst von Yuqian Tang und 5 weiteren Autor:innen. Beteiligte Einrichtung: Key Laboratory of Chinese Medicinal Resource from Lingnan, Ministry of Education, Key Laboratory of Chronic Disease Prevention and Control of Traditi…. Hauptthemen laut MEDLINE: NF-kappa B, Phosphatidylinositol 3-Kinases, Terpenes, Anti-Inflammatory Agents. Die Arbeit nennt 12 Literaturangaben. Gefördert von: National Natural Science Foundation of China, Department of Natural Resources of Guangdong Province, Key Laboratory of Tropical Medicinal Resource Chemistry of Ministry of Education.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Key Laboratory of Chinese Medicinal Resource from Lingnan, Ministry of Education, Key Laboratory of Chronic Disease Prevention and Control of Traditional Chinese Medicine of Guangdong Higher Education Institutes, School…
ORCID-Profile: Hui Cui
Förderung
- National Natural Science Foundation of China
- Department of Natural Resources of Guangdong Province
- Key Laboratory of Tropical Medicinal Resource Chemistry of Ministry of Education
Zitieren
APA
Tang, Y., Yan, D., Liang, C., Wei, J., He, J., & Cui, H. (2026). Unprecedented Meroterpenoids Exert Anti-inflammatory Activity by Targeting NF-κB and PI3K Signaling Pathways. Organic Letters. https://doi.org/10.1021/acs.orglett.5c04695
Vancouver
Tang Y, Yan D, Liang C, Wei J, He J, Cui H. Unprecedented Meroterpenoids Exert Anti-inflammatory Activity by Targeting NF-κB and PI3K Signaling Pathways. Organic Letters. 2026. doi:10.1021/acs.orglett.5c04695
BibTeX
@article{Tang2026,
author = {Tang, Yuqian and Yan, Die and Liang, Chuxing and Wei, Jinqin and He, Jingxin and Cui, Hui},
title = {Unprecedented Meroterpenoids Exert Anti-inflammatory Activity by Targeting NF-κB and PI3K Signaling Pathways},
journal = {Organic Letters},
year = {2026},
doi = {10.1021/acs.orglett.5c04695}
}
EUVIMED